Physical Functioning Throughout Lung Cancer Treatment
LUCAT
1 other identifier
observational
150
1 country
1
Brief Summary
This trial investigates the impact of lung cancer treatment on physical status, symptoms and quality of life. Furthermore this trial investigates possible underlying causes and consequences of deconditioning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2015
CompletedStudy Start
First participant enrolled
July 1, 2015
CompletedFirst Posted
Study publicly available on registry
July 9, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2024
CompletedSeptember 15, 2025
September 1, 2025
9.3 years
June 11, 2015
September 8, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
6MWT
Before start of treatment versus 3 months after treatment initiation
1-minute sit to stand test
Before start of treatment versus 3 months after treatment initiation
SPPB
Before start of treatment versus 3 months after treatment initiation
Secondary Outcomes (4)
Handgrip strength
Before start of treatment vs. 3 months after treatment initiation
Daily physical activity (self-reported and accelerometer)
Before start of treatment vs. during treatment (surgery: during hospitalization; radio: week 2; chemo: beginning of cycle 2 and cycle 4 (each cycle is 3 weeks); immuno: beginning of cycle 2 and cycle 4) vs. 3 months after treatment initiation
Quadriceps strength (isometric and isokinetic)
Before start of treatment vs. 3 months after treatment initiation
Respiratory muscle strength (maximal inspiratory and expiratory pressure)
Before start of treatment vs. 3 months after treatment initiation
Other Outcomes (14)
Comorbidities
Before start of treatment
Number of hospital admissions
12 months after treatment initiation
All cause and cancer-related mortality
12 months after treatment initiation
- +11 more other outcomes
Study Arms (2)
Patients with lung cancer
No study intervention
Healthy controls
No study intervention
Eligibility Criteria
Consecutive patients with a primary diagnosis of non-small-cell lung cancer who will undergo treatment (surgery, chemotherapy, immunotherapy, radiotherapy, and combination of the previous ones) and score a maximal of 2 on the WHO performance status classification, will be eligible for inclusion. Healthy matched volunteers will carry out the same assessments once.
You may qualify if:
- undergoing treatment (surgery, chemotherapy, immunotherapy, radiotherapy, and combination of the previous ones)
- WHO performance status of maximal 2
You may not qualify if:
- presence of other neoplasms in the last 2 years
- bone metastasis
- progressive neuromuscular and neurological diseases
- unstable cardiac disease
- pulmonary hypertension
- interstitial lung disease
- orthopedic conditions that significantly impair functional status
- mental or psychiatric disorders that impair the ability to comply with study procedures.
- a history of cerebrovascular accident with remaining functional consequences
- a history of lung cancer
- difficulties in understanding and speaking Dutch
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ziekenhuis Oost-Limburg
Genk, 3600, Belgium
Related Publications (1)
Quadflieg K, Arents E, Haesevoets S, Van Hulle F, Hermans F, Criel M, Daenen M, Derom E, Spruit MA, Surmont V, Stevens D, Ruttens D, Demeyer H, Burtin C. Impact of cancer treatment on physical functioning, symptoms and health-related quality of life in patients with non-small cell lung cancer: A longitudinal observational study. Respir Med. 2025 Oct;247:108283. doi: 10.1016/j.rmed.2025.108283. Epub 2025 Jul 31.
PMID: 40752628DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
June 11, 2015
First Posted
July 9, 2015
Study Start
July 1, 2015
Primary Completion
October 31, 2024
Study Completion
October 31, 2024
Last Updated
September 15, 2025
Record last verified: 2025-09